Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The document discusses various skin disorders and new therapeutic approaches.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

Sebaceous gland atrophy and abnormal function may contribute to hair loss in psoriasis.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Dr. Jorizzo questions the long-term benefits of minoxidil and tretinoin, while Dr. Olsen defends their effectiveness and stresses the need for public education on these treatments.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Severe hair loss links to metabolic issues in older men with psoriasis.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Advanced human skin models improve drug development and could replace animal testing.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.